Llwytho...
Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
Dolutegravir (DTG) is a second-generation integrase strand transfer inhibitor (INSTI), which has now been licensed to be used in different countries including the UK. Earlier studies have demonstrated that DTG when used with nucleoside backbone in treatment-naïve and - experienced patients has been...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Infect Drug Resist |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4598225/ https://ncbi.nlm.nih.gov/pubmed/26491363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S68396 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|